Clinical trial
Two Doses of Conjugated Estrogen (Premarin) in Patients With…
NCT00134654 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00134654 |
|---|---|
| Title | Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer |
| Official title | A Phase II Trial of Two Doses of Conjugated Estrogens (Premarin) in Patients With Androgen-Independent Prostate Cancer |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Beth Israel Deaconess Medical Center Massachusetts General Hospital Brigham and Women's Hospital Lowell General Hospital South Shore Hospital Emerson Hospital, Concord, MA Saint Anne's Hospital |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Premarin |
| Enrollment | 48 |
| Start date | Mar 1, 2003 |
| Primary completion | Jul 1, 2005 |
| Completion | Jun 1, 2011 |
| First posted | Aug 25, 2005 |
| Last update posted | Jun 16, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: